{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T22:59:32Z","timestamp":1657321172252},"reference-count":23,"publisher":"ALUNA","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>The aim: To revise the case-series of hepatic vascular tumors (HVT), particularly to identify optimal visualization, management and role of surgical intervention. \nMaterials and methods: Out of 96 children with hepatic tumors who hospitalized in a single center from 2011 to 2020, 20 (20,8%) were diagnosed HVT. Hepatic Hemangiomas (HHs) were presented in 19 patients and Kaposiform hemangioendotelioma (KHE) in one case. To determine the type of HH we used radiological classification. For visualisation contrast-enhanced MRI (n=7, 30%) and cCT (n=15,70%) were used. Follow-up period was 14-77 months. \nResults: All HVT were revealed by sonogram at the age of 0-5 m, with 4 (20%) diagnosed prenatally. Male to female ratio was 3:2. Beta-blockers were prescribed to 12 patients with HHs. Treatment duration was from 6 to 24 month. Steroid therapy was initial in cases when it was impossible to prescribe the curative dose of beta-blockers. Complications of propranolol treatment were transitory bradycardia (n=7) and transitory hypoglycemia (n=2). After vincristine chemotherapy decreases the tumor size by 54%, that allowed a safe liver resection. 4 (20%) patients \u2013 two multifocal HHs, one diffuse HH and in patient with KHE manifested congestive heart failure and pulmonary hypertension Mortality rate is 5% (n=1), this patient died against progressive cardiovascular failure. \nConclusions: life-threatening complication of HVT was congestive heart failure. Early treatment is beneficial for complications prevention. Surgical treatment is optional for KHE when can be removed safely.<\/jats:p>","DOI":"10.36740\/wlek202205103","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:35:22Z","timestamp":1656344122000},"page":"1064-1069","source":"Crossref","is-referenced-by-count":0,"title":["HEPATIC VASCULAR TUMORS IN CHILDREN: POTENTIAL RISKS, OPTIMAL IMAGING AND THE ROLE OF SURGICAL INTERVENTION"],"prefix":"10.36740","volume":"75","author":[{"given":"Iryna M.","family":"Benzar","sequence":"first","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatolii F.","family":"Levytskyi","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria S.","family":"Diehtiarova","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg S.","family":"Godik","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Makin E., Davenport M. Fetal and neonatal liver tumours. Early Hum Dev. 2010;86(10):637\u2013642.","DOI":"10.1016\/j.earlhumdev.2010.08.023"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Von Schweinitz D. Neonatal liver tumours. Semin Neonatol. 2003;8:403\u2013410.","DOI":"10.1016\/S1084-2756(03)00092-7"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3. Isaacs Jr. H. Fetal and neonatal hepatic tumours. J Pediatr Surg. 2007;42:1797\u20131803.","DOI":"10.1016\/j.jpedsurg.2007.07.047"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Kuroda T., Kumagai M., Nosaka S. et al. Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group. J Pediatr Surg. 2011;46(12):2239- 2243.","DOI":"10.1016\/j.jpedsurg.2011.09.007"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Rialon K.L., Murillo R., Fevurly R.D. et al. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2015;50(5): 837\u2013841.","DOI":"10.1016\/j.jpedsurg.2014.09.056"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Ji Y., Yang K., Peng S. et al. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon. Br J Dermatol. 2018;179(2):457\u2013463.","DOI":"10.1111\/bjd.16601"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Schmid I., Klenk A. K., Sparber-Sauer M. et al. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options. World J Pediatr. 2018;14(4):322\u2013329.","DOI":"10.1007\/s12519-018-0171-5"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Leaute-Labreze C., Hoeger P., Mazereeuw-Hautier J. et al. A randomized, controlled trial of oral Propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735\u2013746.","DOI":"10.1016\/j.jvs.2015.06.197"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Zavras N., Dimopoulou A., Machairas N. et al. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Euro J Pediatr. 2020;179(1):1\u20138.","DOI":"10.1007\/s00431-019-03504-7"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Vredenborg A.D., Janmohamed S.R., de Laat P.C. et al. Multiple cutaneous infantile haemangiomas and the risk of internal haemangioma. Br J dermatol. 2013;169(1):188\u2013191.","DOI":"10.1111\/bjd.12229"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11. Monroe E.J. Brief Description of ISSVA Classification for Radiologists. Tech Vasc Interv Radiol. 2019;22(4):100628.","DOI":"10.1016\/j.tvir.2019.100628"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12. Kulungowskia A.M., Alomarib A.I., Chawlaa A. et al. Lessons from a liver hemangioma registry: subtype classification. J. of Ped. Surg. 2012;47(1):165\u2013170.","DOI":"10.1016\/j.jpedsurg.2011.10.037"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Benzar I.A Diagnostic Program of Vascular Tumor and Vascular Malformations in Children According to Modern Classification. Acta Medica (Hradec Kralove). 2017;60(1):19\u201326.","DOI":"10.14712\/18059694.2017.47"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Iacobas I., Phung T.L., Adams D.M. et al. Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. J Pediatr. J Pediatr. 2018;203:294\u2013300. doi: 10.1016\/j.jpeds.2018.08.012.","DOI":"10.1016\/j.jpeds.2018.08.012"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Croteau S.E., Liang M.G., Kozakewich H.P. et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142\u2013147.","DOI":"10.1016\/j.jpeds.2012.06.044"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Ji Y., Chen S., Li L. et al. Kaposiform hemangioendothelioma without cutaneous involvement. J Cancer Res Clin Oncol. 2018;144(12):2475\u2013 2484.","DOI":"10.1007\/s00432-018-2759-5"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Kassarjian A., Zurakowski D., Dubois J. et al. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol. 2004;182(3): 785\u2013795.","DOI":"10.2214\/ajr.182.3.1820785"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Gnarra M., Behr G., Kitajewski A. et al. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr. 2016; 8;5(3): 273\u2013280.","DOI":"10.5409\/wjcp.v5.i3.273"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Bosemani T., Puttgen K.B., Huisman T.A. et al. Multifocal infantile hepatic haemangiomas-imaging strategy and response to treatment after Propranolol and steroids including review of the literature. Eur J Pediatr. 2012;171(7):1023\u20131028.","DOI":"10.1007\/s00431-011-1671-7"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Mo J.Q., Dimashkieh H.H., Bove K.E. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol. 2004;35(2): 200\u2013209.","DOI":"10.1016\/j.humpath.2003.09.017"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21. Horii K.A., Drolet B.A., Frieden I.J. et al. Prospective study of the frequency of hepatic haemangiomas in infants with multiple cutaneous infantile haemangiomas. Pediatr Dermatol. 2011;28(3): 245\u2013253.","DOI":"10.1111\/j.1525-1470.2011.01420.x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Li K., Wang Z., Liu Y. et al. Fine clinical differences between patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2016;51(12): 2086\u20132090.","DOI":"10.1016\/j.jpedsurg.2016.09.045"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Huang S.A., Tu H.M., Harney J.W. et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med. 2000;343(3):185\u2013189.","DOI":"10.1056\/nejm200007203430305"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:35:29Z","timestamp":1656344129000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2022\/05\/WLek202205103.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202205103","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}